These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 216480)

  • 1. Detection of humoral immune response to human brain tumors: specificity and reliability of microcytotoxicity assay.
    Wood WC; Kornblith PL; Quindlen EA; Pollock LA
    Cancer; 1979 Jan; 43(1):86-90. PubMed ID: 216480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic antibody responses in astrocytoma patients. An improved allogeneic assay.
    Kornblith PL; Pollock LA; Coakham HB; Quindlen EA; Wood WC
    J Neurosurg; 1979 Jul; 51(1):47-52. PubMed ID: 448418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological evaluation of human brain tumors using a microradioisotopic staphylococcal protein A assay.
    Cohen AM; Wood WC
    J Surg Oncol; 1980; 14(3):219-25. PubMed ID: 6248690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous humoral response to human gliomas and analysis of certain cell surface antigens: in vitro study with the use of microcytotoxicity and immune adherence assays.
    Coakham HB; Kornblith PL; Quindlen EA; Pollock LA; Wood WC; Hartnett LC
    J Natl Cancer Inst; 1980 Feb; 64(2):223-33. PubMed ID: 6153405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunobiology of primary intracranial tumors. Part 3: Microcytotoxicity assays of specific immune responses of brain tumor patients.
    Woosley RE; Mahaley MS; Mahaley JL; Miller GM; Brooks WH
    J Neurosurg; 1977 Dec; 47(6):871-85. PubMed ID: 200722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative cell-mediated immune status of patients with malignant glial tumors.
    Sheikh KM; Apuzzo ML; Weiss MH
    Neurol Res; 1979; 1(2):133-45. PubMed ID: 233266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the humoral response of glioma patients to a possible common tumor-associated antigen(s).
    Martin-Achard A; Diserens AC; de Tribolet N; Carrel S
    Int J Cancer; 1980 Feb; 25(2):219-24. PubMed ID: 7390650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The humoral antibody response of rats immunized with chemically modified syngeneic brain cells and glioma cells.
    Stavrou D; Hultén M; Anzil AP; Bilzer T
    Int J Cancer; 1980 Nov; 26(5):629-37. PubMed ID: 7239719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microcytotoxicity blocking assay for the detection and isolation of soluble astrocytoma association antigen.
    Potter VP; Wood WC; Cohen AM; Kornblith PL
    J Surg Oncol; 1984 Jul; 26(3):188-93. PubMed ID: 6547496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of humoral cytotoxicity testing: the role of rabbit serum, xenoantibody, and human IgM.
    Quindlen EA; Wood WC; Kornblith PL
    J Immunol; 1977 May; 118(5):1836-42. PubMed ID: 858919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-bound antiglial immunity in patients with malignant tumors of the brain.
    Wahlström T; Saksela E; Troupp H
    Cell Immunol; 1973 Feb; 6(2):161-70. PubMed ID: 4348395
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytotoxic antibodies in preoperative glioma patients: a diagnostic assay.
    Phillips JP; Sujatanond M; Martuza RL; Quindlen EA; Wood WC; Kornblith PL; Dohan FC
    Acta Neurochir (Wien); 1976; 35(1-3):43-52. PubMed ID: 961503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological differential diagnosis of human brain tumours.
    Warecka K
    J Neurol Sci; 1975 Dec; 26(4):511-6. PubMed ID: 173807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological analysis of cell surface antigens of malignant human brain tumors.
    Pfreundschuh M; Shiku H; Takahashi T; Ueda R; Ransohoff J; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5122-6. PubMed ID: 283420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A lymphocyte-dependent antibody assay for detection of antibodies to human glioma cells.
    Martuza RL; Shamberger RC; Phillips JP; Kornblith PL; Dohan FC; Hochberg FH
    Surg Forum; 1975; 26():492-4. PubMed ID: 175519
    [No Abstract]   [Full Text] [Related]  

  • 16. Serologic identification of multiple tumor-associated antigens on murine sarcomas.
    Parker GA; Rosenberg SA
    J Natl Cancer Inst; 1977 May; 58(5):1303-9. PubMed ID: 67211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological aspects of experimental brain tumors (review).
    Stavrou D; Bilzer T; Hultén M; Zänker KS; Anzil AP; Haglid KG; Dahme E
    Anticancer Res; 1982; 2(3):151-5. PubMed ID: 6751209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of cell-mediated immunity to a human brain tumor: use of an in vitro microcytotoxicity assay.
    Brem SS; De Tribolet N; Dohan FC; Kornblith PL
    Surg Forum; 1972; 23(0):428-30. PubMed ID: 4671145
    [No Abstract]   [Full Text] [Related]  

  • 19. Soluble membrane antigens of brain tumors. I. Controlled testing for cell-mediated immune responses in a long surviving glioblastoma multiforme patient.
    Hitchcock MH; Hollinshead AC; Chretien P; Rizzoli HV
    Cancer; 1977 Aug; 40(2):660-6. PubMed ID: 196738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal tissue alloantigens and genetic control of susceptibility to tumors: microcytotoxicity studies on resistant C3Hf and susceptible (A X C3Hf) F1 mice inoculated with transplacentally induced C3Hf lung tumor.
    Martin WJ; Esber E; Cotton WG; Rice JM
    J Immunol; 1975 Jul; 115(1):289-295. PubMed ID: 50354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.